Data and PRs, remember? We have little to no data (shareholders), and the PR just told us it’s going to take not one, but three studies to “optimize” the delivery.
I do not understand why you would think the Nasdaq would orgasm over this news. If it goes up, I think it would only slightly bump, before it goes steadily back down until another PR. Why do I think that? Because we already knew it was needing “optimization” BEFORE this announcement, and now we are told it will take three studies to POSSIBLY get there.
